Trinity Biotech Announces Strategic Partnership With Leading New York City Based Provider Of Community-Focused Primary Care

DUBLIN, IRELAND -- (MARKET WIRE) -- February 01, 2007 -- Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced a strategic partnership with Community Healthcare Network (CHN) http://chnnyc.org/ of New York City to introduce Uni-Gold http://www.unigoldhiv.com/ rapid HIV testing across the CHN network of health clinics in the boroughs of Bronx, Brooklyn, Manhattan and Queens.

MORE ON THIS TOPIC